Arbutus Biopharma Corporation   Report issue

For profit Phase 1 Phase 2
Founded: Burnaby BC Canada (1992)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2009
NCT00927459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Arbutus Biopharma Corporation | Tekmira Pharmaceuticals